Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 2
1990 1
1993 2
1995 2
1996 1
1998 2
1999 1
2000 3
2001 1
2002 4
2003 99
2004 171
2005 112
2006 77
2007 64
2008 52
2009 55
2010 42
2011 22
2012 38
2013 33
2014 33
2015 33
2016 40
2017 35
2018 36
2019 27
2020 7135
2021 11181
2022 972
Text availability
Article attribute
Article type
Publication date

Search Results

18,537 results
Results by year
Filters applied: . Clear all
Page 1
Showing results for sars risk
Search for Sari Risku instead (1 results)
Outdoor Transmission of SARS-CoV-2 and Other Respiratory Viruses: A Systematic Review.
Bulfone TC, Malekinejad M, Rutherford GW, Razani N. Bulfone TC, et al. J Infect Dis. 2021 Feb 24;223(4):550-561. doi: 10.1093/infdis/jiaa742. J Infect Dis. 2021. PMID: 33249484 Free PMC article.
BACKGROUND: While risk of outdoor transmission of respiratory viral infections is hypothesized to be low, there are limited data on SARS-CoV-2 transmission in outdoor compared to indoor settings. ...CONCLUSIONS: Existing evidence supports the wide-held belief that …
BACKGROUND: While risk of outdoor transmission of respiratory viral infections is hypothesized to be low, there are limited data on …
Risk factors for severe and critically ill COVID-19 patients: A review.
Gao YD, Ding M, Dong X, Zhang JJ, Kursat Azkur A, Azkur D, Gan H, Sun YL, Fu W, Li W, Liang HL, Cao YY, Yan Q, Cao C, Gao HY, Brüggen MC, van de Veen W, Sokolowska M, Akdis M, Akdis CA. Gao YD, et al. Allergy. 2021 Feb;76(2):428-455. doi: 10.1111/all.14657. Epub 2020 Dec 4. Allergy. 2021. PMID: 33185910 Review.
The pandemic of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused an unprecedented global social and economic impact, and high numbers of deaths. ...In addition, socioeconomic status, diet, lifestyle …
The pandemic of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has …
COVID-19 in Health-Care Workers: A Living Systematic Review and Meta-Analysis of Prevalence, Risk Factors, Clinical Characteristics, and Outcomes.
Gómez-Ochoa SA, Franco OH, Rojas LZ, Raguindin PF, Roa-Díaz ZM, Wyssmann BM, Guevara SLR, Echeverría LE, Glisic M, Muka T. Gómez-Ochoa SA, et al. Am J Epidemiol. 2021 Jan 4;190(1):161-175. doi: 10.1093/aje/kwaa191. Am J Epidemiol. 2021. PMID: 32870978 Free PMC article.
Health-care workers (HCWs) are at the frontline of response to coronavirus disease 2019 (COVID-19), being at a higher risk of acquiring the disease and, subsequently, exposing patients and others. Searches of 8 bibliographic databases were performed to systematically revie …
Health-care workers (HCWs) are at the frontline of response to coronavirus disease 2019 (COVID-19), being at a higher risk of acquiri …
Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study.
Daugherty SE, Guo Y, Heath K, Dasmariñas MC, Jubilo KG, Samranvedhya J, Lipsitch M, Cohen K. Daugherty SE, et al. BMJ. 2021 May 19;373:n1098. doi: 10.1136/bmj.n1098. BMJ. 2021. PMID: 34011492 Free PMC article.
OBJECTIVE: To evaluate the excess risk and relative hazards for developing incident clinical sequelae after the acute phase of SARS-CoV-2 infection in adults aged 18-65. ...The greater risk for incident sequelae after the acute phase of SARS-CoV-2 infe …
OBJECTIVE: To evaluate the excess risk and relative hazards for developing incident clinical sequelae after the acute phase of SAR
SARS-CoV-2 Vaccine Effectiveness in a High-Risk National Population in a Real-World Setting.
Butt AA, Omer SB, Yan P, Shaikh OS, Mayr FB. Butt AA, et al. Ann Intern Med. 2021 Oct;174(10):1404-1408. doi: 10.7326/M21-1577. Epub 2021 Jul 20. Ann Intern Med. 2021. PMID: 34280332 Free PMC article.
INTERVENTION: SARS-CoV-2 vaccination with either the BNT-162b2 (Pfizer-BioNTech) or mRNA-1273 (Moderna) vaccine as part of routine clinical care. ...LIMITATIONS: Predominantly male population; lack of data on disease severity, mortality, and effectiveness by SARS-Co …
INTERVENTION: SARS-CoV-2 vaccination with either the BNT-162b2 (Pfizer-BioNTech) or mRNA-1273 (Moderna) vaccine as part of routine cl …
Mask use during COVID-19: A risk adjusted strategy.
Wang J, Pan L, Tang S, Ji JS, Shi X. Wang J, et al. Environ Pollut. 2020 Nov;266(Pt 1):115099. doi: 10.1016/j.envpol.2020.115099. Epub 2020 Jun 25. Environ Pollut. 2020. PMID: 32623270 Free PMC article. Review.
This study 1) illustrates transmission routes of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2); 2) addresses controversies surrounding the mask from perspectives of attitude, effectiveness, and necessity of wearing the mask with evidence that the use of mask …
This study 1) illustrates transmission routes of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2); 2) addresses controver …
SARS-CoV-2 infection during pregnancy and risk of preeclampsia: a systematic review and meta-analysis.
Conde-Agudelo A, Romero R. Conde-Agudelo A, et al. Am J Obstet Gynecol. 2022 Jan;226(1):68-89.e3. doi: 10.1016/j.ajog.2021.07.009. Epub 2021 Jul 21. Am J Obstet Gynecol. 2022. PMID: 34302772 Free PMC article.
OBJECTIVE: To examine the relationship between SARS-CoV-2 infection during pregnancy and the risk for preeclampsia. ...STUDY ELIGIBILITY CRITERIA: Observational studies that assessed the association between SARS-CoV-2 infection during pregnancy and preeclamps …
OBJECTIVE: To examine the relationship between SARS-CoV-2 infection during pregnancy and the risk for preeclampsia. ...STUDY E …
An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology.
Gresham LM, Marzario B, Dutz J, Kirchhof MG. Gresham LM, et al. J Am Acad Dermatol. 2021 Jun;84(6):1652-1666. doi: 10.1016/j.jaad.2021.01.047. Epub 2021 Jan 19. J Am Acad Dermatol. 2021. PMID: 33482251 Free PMC article. Review.
The vaccine platforms being used to develop SARS-CoV-2 vaccines are expected to be safe and potentially effective for dermatology patients on immunotherapeutics. Current guidelines for the vaccination of an immunocompromised host remain appropriate when considering future …
The vaccine platforms being used to develop SARS-CoV-2 vaccines are expected to be safe and potentially effective for dermatology pat …
COVID-19: dealing with a potential risk factor for chronic neurological disorders.
Schirinzi T, Landi D, Liguori C. Schirinzi T, et al. J Neurol. 2021 Apr;268(4):1171-1178. doi: 10.1007/s00415-020-10131-y. Epub 2020 Aug 27. J Neurol. 2021. PMID: 32852580 Free PMC article. Review.
SARS-CoV2 infection is responsible for a complex clinical syndrome, named Coronavirus Disease 2019 (COVID-19), whose main consequences are severe pneumonia and acute respiratory distress syndrome. ...Specifically, Parkinson's disease, multiple sclerosis and narcolepsy pres
SARS-CoV2 infection is responsible for a complex clinical syndrome, named Coronavirus Disease 2019 (COVID-19), whose main consequence
18,537 results
You have reached the last available page of results. Please see the User Guide for more information.